ResMed Inc.
RMDNYSEHealthcare● Active
$193.14
$-2.90(-1.48%)
Market Cap$28.0B
P/E Ratio—
52W High$293.81
52W Low$180.27
ResMed Inc.（RMD）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · RMD · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $1.40B | $1.02B | $0.90B | $0.78B | $0.47B |
| Depreciation & Amort. | $0.24B | $0.22B | $0.20B | $0.19B | $0.19B |
| Stock-Based Comp. | $0.09B | $0.08B | $0.07B | $0.07B | $0.06B |
| Change in Working Capital | $0.02B | $0.04B | ($0.46B) | ($0.71B) | $0.00B |
| Net Cash from Operations | $1.75B | $1.40B | $0.69B | $0.35B | $0.74B |
| Investing Activities | |||||
| Capital Expenditure | ($0.09B) | ($0.11B) | ($0.13B) | ($0.16B) | ($0.12B) |
| Purchases of Investments | ($0.01B) | ($0.02B) | ($0.03B) | ($0.02B) | ($0.02B) |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Net Cash from Investing | ($0.20B) | ($0.27B) | ($1.16B) | ($0.23B) | ($0.16B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.30B) | ($0.15B) | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.31B) | ($0.28B) | ($0.26B) | ($0.25B) | ($0.23B) |
| Debt Issued / Repaid | ($0.04B) | ($0.73B) | $0.67B | $0.12B | ($0.52B) |
| Net Cash from Financing | ($0.61B) | ($1.12B) | $0.42B | ($0.13B) | ($0.76B) |
| Free Cash Flow | |||||
| Free Cash Flow | $1.66B | $1.29B | $0.56B | $0.20B | $0.62B |
| FCF Margin %(computed) | 32.29% | 27.46% | 13.24% | 5.45% | 19.39% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解ResMed Inc.
关于ResMed Inc.（RMD）现金流量表
ResMed Inc. 2025财年经营活动现金流$1.75B，自由现金流$1.66B（FCF利润率32.29%），资本支出($0.09B)。
常见问题
RMD · 4 问ResMed Inc. 2025财年自由现金流$1.66B，同比up29.2%。
RMD free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10